4//SEC Filing
Vexler Vladimir 4
Accession 0001567619-22-000819
CIK 0001512762other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 7:48 PM ET
Size
7.9 KB
Accession
0001567619-22-000819
Insider Transaction Report
Form 4
Vexler Vladimir
Chief Scientific Officer
Transactions
- Award
Common Stock
2022-01-04+40,000→ 115,154 total - Award
Stock Option (Right to Buy)
2022-01-04+80,000→ 80,000 totalExercise: $15.94Exp: 2032-01-04→ Common Stock (80,000 underlying)
Footnotes (4)
- [F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 4 of each year, with the first 1/3 vesting on January 4, 2023 and with the RSUs being fully vested on January 4, 2025, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
- [F2]Includes 112,083 RSUs.
- [F3]Includes 1,768 shares acquired on November 15, 2021, pursuant to Issuer's employee stock purchase plan.
- [F4]The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 4, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
Documents
Issuer
Coherus BioSciences, Inc.
CIK 0001512762
Entity typeother
Related Parties
1- filerCIK 0001759506
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 7:48 PM ET
- Size
- 7.9 KB